Prolonged Infusion Compared to Standard Infusion Cefepime as Empiric Treatment of Febrile Neutropenia: A Pilot Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01484015

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:52.014359+00:00

Published At

2018-07-18T00:00:00+00:00

Record Updated At

2018-07-18

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Adult Acute Lymphoblastic Leukemia", "Adult Acute Myeloid Leukemia", "Adult Burkitt Lymphoma", "Adult Diffuse Large Cell Lymphoma", "Adult Diffuse Mixed Cell Lymphoma", "Adult Diffuse Small Cleaved Cell Lymphoma", "Adult Hodgkin Lymphoma", "Adult Immunoblastic Large Cell Lymphoma", "Adult Lymphoblastic Lymphoma", "Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative", "Breast Cancer", "Chronic Eosinophilic Leukemia", "Chronic Lymphocytic Leukemia", "Chronic Myelogenous Leukemia", "Chronic Myelomonocytic Leukemia", "Chronic Neutrophilic Leukemia", "Cutaneous T-cell Non-Hodgkin Lymphoma", "Disseminated Neuroblastoma", "Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue", "Grade 1 Follicular Lymphoma", "Grade 2 Follicular Lymphoma", "Grade 3 Follicular Lymphoma", "Malignant Testicular Germ Cell Tumor", "Mantle Cell Lymphoma", "Marginal Zone Lymphoma", "Multiple Myeloma", "Mycosis Fungoides/Sezary Syndrome", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms", "Neutropenia", "Nodal Marginal Zone B-cell Lymphoma", "Ovarian Epithelial Cancer", "Ovarian Germ Cell Tumor", "Plasma Cell Neoplasm", "Poor Prognosis Metastatic Gestational Trophoblastic Tumor", "Primary Myelofibrosis", "Prolymphocytic Leukemia", "Small Lymphocytic Lymphoma", "Splenic Marginal Zone Lymphoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-07-18"

protocolSection.identificationModule.nctId

"NCT01484015"

protocolSection.identificationModule.officialTitle

"Prolonged Infusion Compared to Standard Infusion Cefepime as Empiric Treatment of Febrile Neutropenia: A Pilot Study"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Adult Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
• Adult Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
• Adult Burkitt Lymphoma (protocolSection.conditionsModule.conditions)
• Adult Diffuse Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Adult Diffuse Mixed Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Adult Diffuse Small Cleaved Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
• Adult Immunoblastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Adult Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
• Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative (protocolSection.conditionsModule.conditions)
• Breast Cancer (protocolSection.conditionsModule.conditions)
• Chronic Eosinophilic Leukemia (protocolSection.conditionsModule.conditions)
• Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
• Chronic Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
• Chronic Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
• Chronic Neutrophilic Leukemia (protocolSection.conditionsModule.conditions)
• Cutaneous T-cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
• Disseminated Neuroblastoma (protocolSection.conditionsModule.conditions)
• Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (protocolSection.conditionsModule.conditions)
• Grade 1 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Grade 2 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Grade 3 Follicular Lymphoma (protocolSection.conditionsModule.conditions)
• Malignant Testicular Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
• Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
• Multiple Myeloma (protocolSection.conditionsModule.conditions)
• Mycosis Fungoides/Sezary Syndrome (protocolSection.conditionsModule.conditions)
• Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
• Myelodysplastic/Myeloproliferative Neoplasms (protocolSection.conditionsModule.conditions)
• Neutropenia (protocolSection.conditionsModule.conditions)
• Nodal Marginal Zone B-cell Lymphoma (protocolSection.conditionsModule.conditions)
• Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
• Ovarian Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Plasma Cell Neoplasm (protocolSection.conditionsModule.conditions)
• Poor Prognosis Metastatic Gestational Trophoblastic Tumor (protocolSection.conditionsModule.conditions)
• Primary Myelofibrosis (protocolSection.conditionsModule.conditions)
• Prolymphocytic Leukemia (protocolSection.conditionsModule.conditions)
• Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)
• Splenic Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.